On Wednesday, International Business Machines (NYSE:IBM)’s shares inclined 1.07% to $139.27.
Merge Healthcare, an IBM Company (IBM) and leading provider of clinical systems and innovations that seek to transform healthcare, declared a contract with Greenway Health which aims to automate medical imaging ordering and results delivery work flows for health care professionals nationwide.
Greenway Health’s solutions presently serve 75,000 U.S. health care providers in nearly 10,000 organizations across over 40 specialties, touching more than 100 million lives annually. The partnership will provide Greenway’s customers with access to Merge’s vendor-neutral referral administration platform, called iConnect® Network Services (iCNS). iCNS streamlines the cumbersome and labor-intensive process of placing medical imaging orders, obtaining preceding authorizations from payers and delivering results back to referring providers. These activities are presently performed manually using paper and fax.
“Merge has the infrastructure in place to establish iConnect Network Services as the industry standard for streamlined ordering, preceding authorization and results delivery for medical imaging,” said Greg Shilling, vice president of business and corporate development for Greenway Health. “We are happy to partner with Merge and assist our customers achieve even greater efficiencies in their practices with this solution.”
International Business Machines Corporation provides information technology (IT) products and services worldwide. The company’s Global Technology Services segment provides IT infrastructure and business process services, such as outsourcing, processing, integrated technology, cloud, and technology support.
Wal-Mart Stores, Inc. (NYSE:WMT)’s shares gained 1.11% to $60.30. WMT 52 week range of the stock remained $56.30 - $90.97, while its day lowest price was USD 59.70 and its hit its day highest price at USD 60.65. The company has total of 3.20 billion outstanding shares. It has market cap of $190.96 billion.
Wal-Mart Stores, Inc. operates retail stores in various formats worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sams Club. It operates discount stores, supermarkets, supercenters, hypermarkets, warehouse clubs, cash and carry stores, home improvement stores, specialty electronics stores, restaurants, apparel stores, drug stores, and convenience stores, in addition to retail Websites, such as walmart.com and samsclub.com.
At the end of Wednesday’s trade, Depomed Inc (NASDAQ:DEPO)‘s shares surged 0.47% to $19.13. DEPO has beta value stands at 1.30 times and earnings per share were $0.48. The company has total of 60.48 million outstanding shares and its total market capitalization is $1.15 billion. 52-week price range of the stock remained $14.38 - $33.7.
Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the administration of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
